This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

BBK Worldwide Expands Mobile Strategy For Patient Recruitment To Include "In-App" Advertising

NEWTON, Mass., April 9, 2013 /PRNewswire/ -- In an effort to help clinical trial sponsors capitalize on mobile trends and maximize recruitment dollars, BBK Worldwide (BBK) is releasing a suite of advertising tools for mobile applications – designed to increase campaign effectiveness and return on investment. Developed to complement BBK's existing suite of mobile products and services, this new group of in-app advertising tools creates recruitment opportunities in video, radio, and banner mobile ad networks. BBK Principal and Creative Director Matthew Stumm will be discussing the benefits of these and other mobile tactics at the 22 nd Annual Partnerships in Clinical Trials Conference, which will take place April 21-24 in Orlando, Florida. His presentation, "Web Based Patient Recruitment Insights and Mobile Data Analytics," will be held at 2:00 p.m. on Monday, April 22.

"Mobile advertising has many potential benefits for clinical trial sponsors. Not only does it open doors to untapped audiences of smartphone and tablet users, but it's very effective when combined with desktop advertising," comments Lucas Garmon, media strategist, BBK Worldwide. "From a cost-benefit standpoint, the cost per referral is very attractive, making it a savvy consideration for most clinical trial sponsors."

BBK's approach to mobile draws upon multiple years of experience and strategic insight into current user trends from its in-house media specialists. To remain competitive in an increasing mobile universe, sponsors must integrate mobile or risk losing out on potential audiences. According to the Pew Internet & American Life Project, 31 percent of cell Internet users surveyed mostly go online using their cell phone, and not using some other device such as a desktop or laptop computer ( April 2012).

"Across several campaigns, we're seeing a tremendous upswing in mobile penetration – including one campaign where we're seeing that 48 percent of traffic to the study website is resulting from mobile website optimization," comments Garmon.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,756.97 -41.52 -0.23%
S&P 500 2,085.41 -4.70 -0.22%
NASDAQ 5,104.4380 -23.0870 -0.45%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs